Algaktiv introduced Exometics G, a "revolutionary" biomimetic exosome technology derived from microalgae. According to the company, this innovation delivers exceptional benefits for skin renewal, elasticity and anti-aging while addressing ethical and regulatory concerns of traditional exosomes.
Consistency in Vesicle Dosing
Per Algaktiv, unlike existing solutions with inconsistent concentrations, Exometics G (INCI: Water (Aqua) (and) Propanediol (and) Chlamydomonas Reinhardtii Extract (and) Polyglyceryl-4 Caprate) is precisely dosed at more than 10 billion vesicles per milliliter, allowing brands to claim more than 10 million exosomes per drop in their products. With a controlled particle size of 150 nm for optimal delivery, Exometics G is said to set a new standard for skin care.
Additional advantages are as follows.
- 100% Vegan and cruelty-free: No animal or human-derived materials.
- Unmatched concentration: More than 10 million vesicles per drop for proven efficacy.
- Sustainable and scalable: Lab-grown with limitless production capacity.
- Patented technology: Ensures consistency and maximum potency.
According to Jordi Ayats, product director at Algaktiv, "Exometics G overcomes the limitations of traditional exosomes, providing a standardized, high-potency alternative."
Clinically Proven Results
Exometics G shows significant improvements in skin renewal and rejuvenation effects, the company reports, including:
- 30.6% faster wound healing in eight hours.
- Visible firming effects, as measured by Cutometer.
- A 2.2-year reversal of wrinkles in 14 days.
- A 300% improvement in skin smoothness vs. placebo after 56 days.
- A 25% reduction in hyperpigmentation after 56 days.
- A 15% increase in skin radiance in 28 days.
"Consumers desire effective, ethical skin care," states Alexandre Lapeyre, marketing director. "Exometics G represents a leap forward in delivering scientifically validated exosomes for next-generation skin care."
